EXHIBIT 11.1 NEUROGEN CORPORATION COMPUTATION OF NET INCOME (LOSS) PER COMMON SHARE (in thousands, except Net Income (Loss) per Common Share amounts) THREE MONTHS THREE MONTHS NINE MONTHS NINE MONTHS ENDED ENDED ENDED ENDED SEPT. 30, 1997 SEPT. 30, 1996 SEPT. 30, 1997 SEPT. 30, 1996 (UNAUDITED) (UNAUDITED) (UNAUDITED) (UNAUDITED) --------------- --------------- --------------- --------------- Primary: Weighted average shares of common stock outstanding 14,362 14,192 14,332 14,118 Dilutive effect of : Warrants (1) 42 36 43 Stock options (1) 1,151 1,022 1,305 --------------- --------------- --------------- --------------- Common and common equivalent shares 14,362 15,385 15,390 15,466 =============== =============== =============== =============== Net income (loss) $ (922) $ 332 1,673 $ 5,060 =============== =============== =============== =============== Earnings (loss) per common and common equivalent shares $ (0.06) $ .02 $ 0.11 0.33 =============== =============== =============== =============== Fully Diluted: Weighted average shares of common stock outstanding 14,362 14,192 14,332 14,118 Dilutive effect of : Warrants (1) 42 36 43 Stock options (1) 1,215 1,314 1,305 --------------- --------------- --------------- --------------- Common and common equivalent shares 14,362 15,449 15,682 15,466 =============== =============== =============== =============== Net income (loss) $ (922) $ 332 1,673 $ 5,060 =============== =============== =============== =============== Earnings (loss) per common and common equivalent shares $ (0.06) $ .02 $ 0.11 0.33 =============== =============== =============== =============== (1) The Common Stock Equivalents have not been included as their inclusion would be antidilutive.